ACGIH. 1999. Bioaerosols Assessment and Control. (J. Machler, Ed.). American Conference of Industrial Hygienists, Cincinnati, OH.

Ajello, L. and R. Hay. 1998. Topley & Wilson's Microbiology and Microbial Infections, 9th ed., Vol. 4: Medical Mycology, Edward Arnold, New York.

American Academy of Pediatrics (AAP).  1998. Toxic effects of indoor molds.  Pediatrics 101:712-714.

Ammann, H.M. 1999. Microbial Volatile Organic Compounds. In: Bioaerosols Assessment and Control. (J. Machler, Ed.). American Conference of Industrial Hygienists, Cincinnati, OH.

Apostolakos, M.J., H. Rossmoore, W.S. Beckett.  Hypersensitivity pneumonitis from ordinary residential exposures.  Environmental Health Perspectives 109:979-981.

Burge, H.A. and H.A. Ammann. 1999. Fungal Toxins and b-(1-3)-D-Glucans. In: Bioaerosols Assessment and Control. (J. Machler, Ed.). American Conference of Industrial Hygienists, Cincinnati, OH.

Burge, H.A. and J.A. Otten. 1999. Fungi. In: Bioaerosols Assessment and Control. (J. Machler, Ed.). American Conference of Industrial Hygienists, Cincinnati, OH.

Bush, R.K. and J.J. Prochnau. 2004. Alternaria-induced asthma. J Allergy Clin Immunol. 113:227-34.

Croft, W.A., B.M. Jastromski, A.L. Croft, and H.A. Peters. 2002. Clinical confirmation of trichothecene mycotoxicosis in patient urine.  J. Environ. Biol. 23:301-320.

Curtis, L.,  A. Lieberman,  M. Stark, W. Rea, and M. Vetter.  2004.  Adverse Health Effects of Indoor Molds.  Journal of Nutritional and Environmental Medicine.  14:261-274.

Dennis, D. 2003.  Chronic sinusitis: defective T-cells responding to superantigens, treated by reduction of fungi in the nose and air.  Archives of Environmental Health 58:433-441.

EPA (U.S. Environmental Protection Agency). 1994.  Indoor Air Pollution: An Introduction for Health Professionals: U.S. Government Printing Office Publication No. 1994-523-217/81322, 1994:   http://www.epa.gov/iaq/pubs/images/indoor_air_pollution.pdf

EPA (U.S. Environmental Protection Agency). 1997. Should you have the air ducts in your home cleaned? Indoor Environments Division, Office of Air and Radiation, EPA-402-K-97-002. http://www.epa.gov/iedweb00/pubs/airduct.html

EPA (U.S. Environmental Protection Agency). 2001. Mold Remediation in Schools and Commercial Buildings: Office of Air and Radiation, Indoor Environments Division (6609-J) EPA 402-K-01-001, March 2001. http://www.epa.gov/iaq/molds/mold_remediation.html

Gent J.F., P. Ren, K. Belanger, E. Triche, M.B. Bracken, T.R. Holford, and B.P. Leaderer. 2002. Levels of household mold associated with respiratory symptoms in the first year of life in a cohort at risk for asthma. Environ Health Perspect.110:A781-6.

Gorny R.L., T. Reponen, K. Willeke, D. Schmechel, E. Robine, M. Boissier, and S.A. Grinshpun.  2002.  Fungal fragments as indoor air biocontaminants.  Appl Environ Microbiol. 68:3522-3531.

Gray, M.R., J.D. Thrasher, R. Crago, R.A. Madison, L. Arnold, A.W. Campbell, and A. Vojdani.  2003. Mixed mold mycotoxicosis: immunological changes in humans following exposure in water-damaged buildings.  Archives of Environmental Health 58:410-420.

Hardin, B.D., B.J. Kelman, and A. Saxon. 2003. Adverse human health effects associated with molds in the indoor environment. J. Occup. Environ. Med. 45:470-478.

Health Canada. 1995. Fungal Contamination in Public Buildings: A Guide to Recognition and Management.  Federal-Provincial Committee on Environmental and Occupational Health, Ottawa, Ontario

Hendry, K.M. and E.C. Cole. 1993. A Review of Mycotoxins in Indoor Air. Journal of Toxicology and Environmental Health 38:183-198.

Henderson, L.T., K.T. Robbins, S. Weitzner, T.C. Dyer, and R.A. Jahrsdoerfer. 1988. Benign Mucor colonization (fungus ball) associated with chronic sinusitis. South Med J. 81:846-50.

Horner, W.E., A. Helbling, and J.E. Salvaggio.1995. Fungal allergens. Clin. Micro. Rev. 8:161-179.

Kilburn, K. 2003. Indoor mold exposure associated with neurobehavioral and pulmonary impairment: a preliminary report.  Archives of Environmental Health 58:390-398.

Koivikko, A., M. Viander, and A. Lanner. 1991. Use of the extended Phadebas RAST panel in the diagnosis of mould allergy in asthmatic children. Allergy. 46:85-91.

Kuhn, D.M. and M.A. Ghannoum.  2003.  Indoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious disease perspective. Clin Microbiol Rev.16:144-172.

Lander, F., H.W. Meyer, and  S. Norn  2001. Serum IgE specific to indoor moulds, measured by basophil histamine release, is associated with building-related symptoms in damp buildings. Inflamm. Res. 50:227-31.

Lee, S.K., S.S Kim, D.H. Nahm, H.S. Park, Y.J. Oh, K.J. Park, S.O. Kim, and S.J. Kim. 2000. Hypersensitivity pneumonitis caused by Fusarium napiforme in a home environment. Allergy. 55:1190-1193. 

Lin, R.Y. and K.D. Williams. 2003. Hypersensitivity to molds in New York City in adults who have asthma. Allergy Asthma Proc. 24:13-8.

Mari, A., P. Schneider, V. Wally, M. Breitenbach, and B. Simon-Nobbe.  2003.  Sensitization to fungi: epidemiology, comparative skin tests, and IgE reactivity of fungal extracts. Clin Exp Allergy. 33:1429-1438.

Institute of Medicine. 2004.  Damp Indoor Spaces and Health. National Academies Press, Washington D.C.

NYCDH (New York City Department of Health) 2003. Bureau of Environmental & Occupational Disease Epidemiology Guidelines on Assessment and Remediation of Fungi in Indoor Environments: http://www.ci.nyc.ny.us/html/doh/html/epi/moldrpt1.html

Patterson, R., J.N. Fink, W.B. Miles, J.E. Basich, D.B. Schleuter, D.G. Tinkelman, and M. Roberts.  1981. Hypersensitivity lung disease presumptively due to Cephalosporium in homes contaminated by sewage flooding or by humidifier water. J. Allergy Clin Immunol. 68:128-32. 

Ponikau, J.U., D.A. Sherris, E.B. Kern, H.A. Homburger, E. Frigas,T.A. Gaffey, and G.D. Roberts. 1999. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin. Proc. 74:877-884.

Rautiala, S., T. Reponen, A. Hyvarinen, A. Nevalainen, T. Husman, A. Vehvilainen, Pentti Kalliokoski. 1996. Exposure to Airborne Microbes During the Repair of Moldy Buildings. AIHA Journal 57:279-284.

Rea, W., N. Didriksen, T.R. Simon, Y. Pan, E.J. Fenyves, and B. Griffiths.  2003.  Effects of toxic exposure to molds and mycotoxins in building-related illness.  Archives of Environmental Health 58:399-405.

Robbins, C. A., L.J. Swenson, M.L. Nealley, B.J. Kelman, and R.E. Gots. 2000. Health Effects of Mycotoxins in Indoor Air: A Critical Review. Applied Occupational and Environmental Hygiene 15:773-784

Rose et al. 1999. Medical Roles and Recommendations. In: Bioaerosols Assessment and Control. (J. Machler, Ed.). American Conference of Industrial Hygienists, Cincinnati, OH.

Rylander, R. and R.H. Lin. 2000. (1®3)-Beta-D-glucan – relationship to indoor air-related symptoms, allergy and asthma.  Toxicology 152:47-52.

Saini, S.K., S.R. Boas, A. Jerath, M. Roberts, and P.A. Greenberger 1998. Allergic bronchopulmonary mycosis to Fusarium vasinfectum in a child. Ann Allergy Asthma Immunol. 80:377-380.

Sanchez, H. and R.K. Bush. 2001. A review of Alternaria alternata sensitivity.  Rev. Iberoam. Microl. 18:56-59.

Van Emon, J.M., A.W. Reed, I. Yike, and S.J. Vesper. 2003.  ELISA measurement of stachylysin in serum to quantify human exposures to the indoor mold Stachybotrys chartarum. J. Occup. Environ. Med. 45:582-591.

Vojdani, A., J.D. Thrasher, R.A. Madison, M.R. Gray, G. Heuser, and A. W. Campbell.  2003.  Antibodies to molds and satratoxin in individuals exposed in water-damaged buildings.  Archives of Environmental Health 58:421-432.

Wallace, L.A. 1997. Sick Building Syndrome. In: Indoor Air Pollution and Health E.J. Bardana Jr. and A. Montanaro (Eds). Marcel Dekker, Inc., New York.

Woodard, E.D., B. Friedlander, R.J. Lesher, W. Font, R. Kinsey, and F.T. Hearne. 1988. Outbreak of hypersensitivity pneumonitis in an industrial setting. JAMA. 259:1965-1969

Yang C., and E. Johanning, 1996. Airborne Fungi and Mycotoxins, In: Manual of Environmental Microbiology, C. Hurst (Editor in Chief), ASM Press, Washington, D.C.